Darko Ursic, Katja Berginc, Simon Zakelj, Albin Kristl, Darko Ursic, Katja Berginc, Simon Zakelj, Albin Kristl, Darko Uršič, Katja Berginc, Simon Žakelj, Albin Kristl
Index: Int. J. Pharm. 381(2) , 199-204, (2009)
Full Text: HTML
Intestinal efflux transporters can significantly reduce the absorption of the drug after peroral application. In this work we studied secretion of glutathione conjugates triggered by glucose at the luminal side of the intestine. Glucose stimulated secretion of DNPSG, NEMSG and CDNB. We used some different monosaccharides and determined that glucose, galactose and alpha-methylglucopyranoside trigger the secretion, while mannitol and fructose do not. We concluded that interaction with SGLT transporter is the key process necessary for this triggering. To determine which of possible glutathione conjugate transporters (MRP2, MRP4, BCRP or RLIP76) is responsible for the secretion of glutathione conjugates, we used benzbromarone, a MRP inhibitor, and sulfanitran and furosemide, two allosteric MRP2 activators. Benzbromarone inhibited glucose stimulated DNPSG secretion, while allosteric activators additionally increased the secretion. We concluded that MRP2 transporter is related to glucose stimulated DNPSG secretion. Regarding the work of Kubitz et al. we tested the effect of changed medium osmolarity on DNPSG transport and determined that hypoosmolar conditions trigger secretion of DNPSG. These findings suggest that intestinal MRP2 activity has no basal level, but can be stimulated by hypoosmolarity and SGLT transport.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Sulfanitran
CAS:122-16-7 |
C14H13N3O5S |
Validation of a streamlined multiclass, multiresidue method ...
2015-06-01 [Anal. Bioanal. Chem 407 , 4423-35, (2015)] |
[Determination of 12 sulfonamides in cosmetics by ultra perf...
2007-03-01 [Se Pu 25(2) , 238-40, (2007)] |
Transport of diclofenac by breast cancer resistance protein ...
2009-01-01 [Drug Metab. Dispos. 37 , 129-136, (2009)] |
Evidence for two interacting ligand binding sites in human m...
2003-06-27 [J. Biol. Chem. 278 , 23538-23544, (2003)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved